Baird Financial Group’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,000
| Closed | -$6.88K | – | 1792 |
|
|
2023
Q4 | $6.88K | Hold |
1,000
| – | – | ﹤0.01% | 1705 |
|
|
2023
Q3 | $6.3K | Hold |
1,000
| – | – | ﹤0.01% | 1705 |
|
|
2023
Q2 | $8.3K | Hold |
1,000
| – | – | ﹤0.01% | 1682 |
|
|
2023
Q1 | $4.4K | Hold |
1,000
| – | – | ﹤0.01% | 1683 |
|
|
2022
Q4 | $6K | Buy |
+1,000
| New | +$6K | ﹤0.01% | 1679 |
|